We are live on ! Find out more
PM

Ponoi Management Portfolio holdings

AUM $73.2M
1-Year Est. Return 23.44%
This Fund
S&P 500
This Quarter Est. Return
+27.82%
1 Year Est. Return
-23.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
–
Cap. Flow
+$169M
Cap. Flow %
96.72%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$47.3M
2
RAPT
RAPT Therapeutics
RAPT
+$43.5M
3
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$28.4M
4
RVMD icon
Revolution Medicines
RVMD
+$27.1M
5
NRIX icon
Nurix Therapeutics
NRIX
+$22.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$54.2M 30.99%
+1,880,623
New +$47.3M
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$39.4M 22.52%
+1,298,908
New +$28.4M
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$31.6M 18.07%
+199,927
New +$43.5M
RVMD icon
4
Revolution Medicines
RVMD
$47.4B
$27.1M 15.52%
+685,011
New +$27.1M
NRIX icon
5
Nurix Therapeutics
NRIX
$2.79B
$22.6M 12.91%
+686,274
New +$22.7M

Similar funds

RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
SMC
S. Muoio & Co New York $75.7M AUM 42.51% 1-Year Est. Return
CCM
Composite Capital Management Hong Kong $70.1M AUM 79.53% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return

Ponoi Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Ponoi Management, which disclosed 5 positions worth $175M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Constellation Pharmaceuticals, Inc.: 1,880,623 shares worth $54.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ponoi Management's largest Q4 2020 buy was Constellation Pharmaceuticals, Inc.: 1,880,623 shares worth $54.2M.
  • Ponoi Management's ten largest holdings make up 100% of its $175M portfolio in Q4 2020.
  • Ponoi Management disclosed 5 positions in Q4 2020, its first 13F filing on record.

Based on Ponoi Management's 13F filing for Q4 2020, filed 16 Feb 2021.